DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+21.45%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.75B
AUM Growth
+$332M
(+6.1%)
Cap. Flow
-$834M
Cap. Flow
% of AUM
-14.52%
Top 10 Holdings %
Top 10 Hldgs %
51.71%
Holding
447
New
223
Increased
65
Reduced
45
Closed
77
Top Buys
| 1 |
BioNTech
BNTX
|
$52.5M |
| 2 |
Kyverna Therapeutics
KYTX
|
$36.3M |
| 3 |
Perspective Therapeutics
CATX
|
$33.5M |
| 4 |
Larimar Therapeutics
LRMR
|
$32.6M |
| 5 |
Surgery Partners
SGRY
|
$32.3M |
Top Sells
| 1 |
Viking Therapeutics
VKTX
|
$66.9M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$64M |
| 3 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$62.6M |
| 4 |
Baxter International
BAX
|
$57.8M |
| 5 |
Neurocrine Biosciences
NBIX
|
$28.4M |
Sector Composition
| 1 | Healthcare | 88.87% |
| 2 | Industrials | 0.71% |
| 3 | Technology | 0.31% |
| 4 | Consumer Discretionary | 0.26% |
| 5 | Financials | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Warner Bros
WBD
$30B
| $413K | 0.01% |
47,346
+28,145
| +147% | +$246K |
|
177
Northern Trust
NTRS
$24.3B
| $407K | 0.01% |
4,582
+1,482
| +48% | +$132K |
|
178
Boeing
BA
$174B
| $407K | 0.01% |
+2,109
| New | +$407K |
|
179
Five Below
FIVE
$8.46B
| $405K | 0.01% |
+2,232
| New | +$405K |
|
180
Cytokinetics
CYTK
$6.34B
| $404K | 0.01% |
5,764
+2,600
| +82% | +$182K |
|
181
General Motors
GM
$55.5B
| $398K | 0.01% |
8,774
+1,698
| +24% | +$77K |
|
182
Bain Capital Specialty
BCSF
$1.02B
| $398K | 0.01% |
+25,356
| New | +$398K |
|
183
ESAB
ESAB
$7.15B
| $392K | 0.01% |
+3,546
| New | +$392K |
|
184
Globe Life
GL
$11.3B
| $391K | 0.01% |
+3,363
| New | +$391K |
|
185
GoPro
GPRO
$236M
| $391K | 0.01% |
175,149
+141,036
| +413% | +$315K |
|
186
Huron Consulting
HURN
$2.44B
| $388K | 0.01% |
4,015
+950
| +31% | +$91.8K |
|
187
Brighthouse Financial
BHF
$2.48B
| $388K | 0.01% |
+7,520
| New | +$388K |
|
188
Matthews International
MATW
$767M
| $387K | 0.01% |
+12,438
| New | +$387K |
|
189
HCI Group
HCI
$2.21B
| $387K | 0.01% |
3,330
-740
| -18% | -$85.9K |
|
190
DuPont de Nemours
DD
$32.6B
| $385K | 0.01% |
+5,021
| New | +$385K |
|
191
Hexcel
HXL
$5.16B
| $383K | 0.01% |
5,259
+1,027
| +24% | +$74.8K |
|
192
HealthEquity
HQY
$7.88B
| $380K | 0.01% |
+4,660
| New | +$380K |
|
193
Incyte
INCY
$16.9B
| $380K | 0.01% |
6,672
+2,007
| +43% | +$114K |
|
194
Bright Horizons
BFAM
$6.64B
| $378K | 0.01% |
+3,332
| New | +$378K |
|
195
Kelly Services Class A
KELYA
$489M
| $377K | 0.01% |
+15,063
| New | +$377K |
|
196
BellRing Brands
BRBR
$4.97B
| $374K | 0.01% |
+6,344
| New | +$374K |
|
197
Jacobs Solutions
J
$17.4B
| $372K | 0.01% |
+2,928
| New | +$372K |
|
198
InvenTrust Properties
IVT
$2.33B
| $372K | 0.01% |
+14,470
| New | +$372K |
|
199
Oracle
ORCL
$654B
| $371K | 0.01% |
+2,950
| New | +$371K |
|
200
Deluxe
DLX
$876M
| $368K | 0.01% |
+17,885
| New | +$368K |
|